| [1] |
Sun MT, Tsai CH, Shih KC.Antithyroid drug-induced agranulocytosis[J].J Chin Med Assoc, 2009, 72(8): 438-441.
|
| [2] |
Finucane FM, O' Connell J, Kinsley BT.Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy[J].Ir J Med Sci, 2008, 177(1): 69-71.
|
| [3] |
Tsuboi K, Ueshiba H, Shimojo M, et al.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves′ disease[J].Endocr J, 2007, 54(1): 39-43.
|
| [4] |
Tamai H, Sudo T, Kimura A, et al.Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J].Ann Intern Med, 1996, 124(5): 490-494.
|
| [5] |
Cooper DS, Goldminz D, Levin AA, et al.Agranulocytosis associated with antithyroid drugs.Effects of patient age and drug dose[J].Ann Intern Med, 1983, 98(1): 26-29.
|
| [6] |
Werner MC, Romaldini JH, Bromberg N, et al.Adverse effects related to thionamide drugs and their dose regimen[J].Am J Med Sci, 1989, 297(4): 216-219.
|
| [7] |
Bahn RS, Burch HB, Cooper DS, et al.Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J].Endocr Pract, 2011, 17(3): 456-520.
|
| [8] |
Andrès E, Kurtz JE, Perrin AE, et al.Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis[J].QJM, 2001, 94(8): 423-428.
|
| [9] |
Garbe E.Non-chemotherapy drug-induced agranulocytosis[J].Expert Opin Drug Saf, 2007, 6(3): 323-335.
|
| [10] |
Tamai H, Mukuta T, Matsubayashi S, et al.Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor(rhG-CSF)[J].J Clin Endocrinol Metab, 1993, 77(5): 1356-1360.
|
| [11] |
徐丹, 李路, 袁凤易.抗甲状腺药物致粒细胞缺乏症46例临床分析[J].实用临床医学, 2007, 8(8): 22-24.
|